Sanofi | SAN - Selling And Administration Expenses



Sanofi reported EUR2.68B in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.

Selling And Administration Expenses Change Date
AbbVie USD 4.2B 863M Sep/2024
Aena EUR 150.26M 1.09M Sep/2024
Alcon AG USD 837M 35M Jun/2024
Almirall EUR -50222000 162.22M Jun/2024
Amarin USD 36.9M 1.65M Sep/2024
Amgen USD 1.62B 61M Sep/2024
AstraZeneca USD 5.25B 226M Sep/2024
Bayer EUR 3.72B 325M Sep/2024
Biogen USD 588.4M 34.6M Sep/2024
BMW EUR 2.67B 288M Sep/2024
Bristol-Myers Squibb USD 1.98B 55M Sep/2024
Eli Lilly USD 2.1B 17.5M Sep/2024
Essilor EUR 3.07B 1.97B Jun/2024
Fresenius EUR 701M 102M Sep/2024
Fresenius Medical Care EUR 756M 15.47M Sep/2024
Galapagos EUR 29.26M 3.88M Sep/2024
Genmab DKK 865M 29M Sep/2024
Gilead Sciences USD 1.4B 28M Sep/2024
GlaxoSmithKline GBP 3.8B 1.41B Sep/2024
GRIFOLS EUR 327.34M 11.2M Jun/2024
Hikma Pharmaceutical USD 140M 144M Jun/2024
J&J USD 5.48B 29M Sep/2024
Mercedes-Benz AG EUR 2.41B 650M Sep/2024
Merck EUR 1.48B 63M Jun/2024
Merck USD 2.66B 51M Sep/2024
Novartis USD 3.13B 42M Sep/2024
Orion EUR 85.8M 5.6M Sep/2024
Pfizer USD 3.22B 341M Sep/2024
Philips EUR 1.23B 59M Sep/2024
Recordati EUR 164.83M 8.36M Jun/2024
Regeneron Pharmaceuticals USD 714.4M 44.4M Sep/2024
Roche Holding CHF 3.23B 3.29B Jun/2024
Sanofi EUR 2.68B 26M Sep/2024
Sanofi EUR 2.68B 26M Sep/2024
SAP EUR 2.39B 159M Sep/2024
UCB EUR 533M 434M Jun/2024
Vinci EUR 167M 17.77B Jun/2024
Volkswagen EUR 8.25B 555M Sep/2024